Načítá se...
2383. In Vitro Activity of Ceftolozane–Tazobactam in Comparison With Ceftazidime–Avibactam vs. Antimicrobial Non-Susceptible Pseudomonas aeruginosa Clinical Isolates, Including Multidrug-Resistant and Extensively Drug-Resistant Subsets: CANWARD, 2007–2017
BACKGROUND: Pseudomonas aeruginosa (PA) is an important nosocomial pathogen. Treatment options for infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) isolates remain limited. Ceftolozane-tazobactam (C/T) and ceftazidime–avibactam (CZA) are two newer antimicrobials wi...
Uloženo v:
| Vydáno v: | Open Forum Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6255566/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2036 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|